Biogen (BIIB) PT Lowered to $272 at Cantor Fitzgerald
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $218.50 -1.35%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Cantor Fitzgerald lowered its price target on Biogen (NASDAQ: BIIB) to $272.00 (from $289.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elastic NV. (ESTC) PT Raised to $100 at Cantor Fitzgerald on Expanding Group Multiples
- Sunny Optical Technology Group Co Ltd (2382:HK) (SNPTF) PT Raised to HK$82.35 at Macquarie
- Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
